Immediate Impact
22 standout
Citing Papers
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
2024 Standout
Innate immune activation in neurodegenerative diseases
2024 Standout
Works of Danielle Riley being referenced
Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial
2021
The association of socioeconomic status with receipt of neoadjuvant chemotherapy
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Danielle Riley | 38 | 14 | 5 | 20 | 8 | 74 | |
| Viktoria Schwarz | 42 | 7 | 1 | 31 | 7 | 174 | |
| Greg S. Warnick | 35 | 14 | 16 | 27 | 7 | 179 | |
| Gary Osborn | 28 | 42 | 32 | 14 | 11 | 90 | |
| Marla Daves | 35 | 12 | 3 | 4 | 9 | 117 | |
| Ellen M Goldberg | 25 | 15 | 31 | 22 | 10 | 87 | |
| Ngoc‐Thanh Kim | 12 | 10 | 2 | 47 | 7 | 81 | |
| Madhuri Are | 36 | 12 | 8 | 45 | 7 | 163 | |
| Jennifer Yam | 64 | 5 | 12 | 17 | 8 | 120 | |
| Geoffrey Delmore | 73 | 8 | 5 | 26 | 8 | 181 | |
| Azizah Ab Manan | 32 | 7 | 3 | 16 | 9 | 76 |
All Works
Login with ORCID to disown or claim papers
Loading papers...